More importantly, we found a similar trend in different tumors, such as STAD, COAD, KIRC, PRAD, CESC, etc. These findings implied that high P4HA1 expression was associated with tumor immune microenvironment inhibition in pan-cancer. The gene discussed is P4HA1; the disease is cancer.